Literature DB >> 9239759

The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies.

K Barnes1, A J Turner.   

Abstract

The biologically active vasoactive peptides, the endothelins (ETs), are generated from inactive intermediates, the big endothelins, by a unique processing event catalysed by the zinc metalloprotease, endothelin converting enzyme (ECE). In this overview we examine the actions of endothelins in the brain, and focus on the structure and cellular locations of ECE. The heterogeneous distribution in the brain of ET-1, ET-2, and ET-3 is discussed in relation to their hemodynamic, mitogenic and proliferative properties as well as their possible roles as neurotransmitters. The cellular and subcellular localization of ECE in neuronal and in glial cells is compared with that of other brain membrane metalloproteases, neutral endopeptidase-24.11 (neprilysin), angiotensin converting enzyme and aminopeptidase N, which all function in neuropeptide processing and metabolism Unlike these ectoenzymes, ECE exhibits a dual localisation in the cell, being present on the plasma membrane and also, in some instances, being concentrated in a perinuclear region. This differential localization may reflect distinct targeting of different ECE isoforms, ECE-1 alpha, ECE-1 beta, and ECE-2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9239759     DOI: 10.1023/a:1022435111928

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  71 in total

1.  Electron microscopic localization of immunoreactive enkephalinase (EC 3.4.24.11) in the neostriatum of the rat.

Authors:  D Marcel; H Pollard; P Verroust; J C Schwartz; A Beaudet
Journal:  J Neurosci       Date:  1990-08       Impact factor: 6.167

2.  A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes.

Authors:  H Ehrenreich; J H Kehrl; R W Anderson; P Rieckmann; L Vitkovic; J E Coligan; A S Fauci
Journal:  Brain Res       Date:  1991-01-04       Impact factor: 3.252

3.  Expression of endothelin-converting enzyme in both neuroblastoma and glial cell lines and its localization in rat hippocampus.

Authors:  K Barnes; B J Walkden; T C Wilkinson; A J Turner
Journal:  J Neurochem       Date:  1997-02       Impact factor: 5.372

4.  The angiotensin I-converting enzyme.

Authors:  E G Erdös; R A Skidgel
Journal:  Lab Invest       Date:  1987-04       Impact factor: 5.662

5.  Electronmicroscopic immunocytochemistry of pig brain shows that endopeptidase-24.11 is localized in neuronal membranes.

Authors:  K Barnes; A J Turner; A J Kenny
Journal:  Neurosci Lett       Date:  1988-11-22       Impact factor: 3.046

6.  The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity.

Authors:  C F Deschepper; A D Houweling; S Picard
Journal:  Eur J Pharmacol       Date:  1995-02-24       Impact factor: 4.432

7.  Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia.

Authors:  A Giaid; S J Gibson; B N Ibrahim; S Legon; S R Bloom; M Yanagisawa; T Masaki; I M Varndell; J M Polak
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells.

Authors:  K Shimada; M Takahashi; K Tanzawa
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

9.  Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.

Authors:  K Shimada; M Takahashi; A J Turner; K Tanzawa
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice.

Authors:  M Gautam; P G Noakes; J Mudd; M Nichol; G C Chu; J R Sanes; J P Merlie
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

View more
  12 in total

1.  N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface.

Authors:  V Hospital; V Chesneau; A Balogh; C Joulie; N G Seidah; P Cohen; A Prat
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

2.  Differential glial and vascular expression of endothelins and their receptors in rat brain after neurotrauma.

Authors:  A L Sirén; F Knerlich; L Schilling; H Kamrowski-Kruck; A Hahn; H Ehrenreich
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

3.  Intraspinal application of endothelin results in focal ischemic injury of spinal gray matter and restricts the differentiation of engrafted neural stem cells.

Authors:  Richard L Benton; John P Woock; Evelyne Gozal; Michal Hetman; Scott R Whittemore
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

4.  Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.

Authors:  Suqing Wang; Rui Wang; Lang Chen; David A Bennett; Dennis W Dickson; Deng-Shun Wang
Journal:  J Neurochem       Date:  2010-07-30       Impact factor: 5.372

Review 5.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

6.  Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells.

Authors:  Rui Wang; Suqing Wang; James S Malter; Deng-Shun Wang
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Targeting endothelin receptors A and B attenuates the inflammatory response and improves locomotor function following spinal cord injury in mice.

Authors:  Jian Guo; Yiqiao Li; Zhennian He; Bin Zhang; Yonghuan Li; Jianghua Hu; Mingyuan Han; Yuanlin Xu; Yongfu Li; Jie Gu; Bo Dai; Zhong Chen
Journal:  Int J Mol Med       Date:  2014-04-22       Impact factor: 4.101

Review 8.  Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.

Authors:  Natalia N Nalivaeva; Nikolai D Belyaev; Caroline Kerridge; Anthony J Turner
Journal:  Front Aging Neurosci       Date:  2014-09-17       Impact factor: 5.750

9.  Investigation of the Molecular Mechanisms by Which Endothelin-3 Stimulates Preadipocyte Growth.

Authors:  An-Ci Siao; Li-Jane Shih; Yen-Yue Lin; Yi-Wei Tsuei; Yow-Chii Kuo; Hui-Chen Ku; Chih-Ping Chuu; Po-Jen Hsiao; Yung-Hsi Kao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555

10.  Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins.

Authors:  Benjamin E Padilla; Graeme S Cottrell; Dirk Roosterman; Stella Pikios; Laurent Muller; Martin Steinhoff; Nigel W Bunnett
Journal:  J Cell Biol       Date:  2007-11-26       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.